International Assets Investment Management’s Biogen BIIB Stock Holding History

International Assets Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,852	Closed	-$359K	–	933
2024 Q3	$359K	Buy	1,852 +41	+2%	+$8.58K	0.03%	426
2024 Q2	$420K	Buy	1,811 +100	+6%	+$21.7K	0.04%	426
2024 Q1	$368K	Sell	1,711 -132	-7%	-$30.9K	0.04%	453
2023 Q4	$477K	Sell	1,843 -78	-4%	-$19.2K	0.06%	361
2023 Q3	$495K	Buy	1,921 +1,045	+119%	+$280K	0.07%	273
2023 Q2	$250K	Buy	+876	New	+$261K	0.03%	437
2023 Q1	–	Sell	-885	Closed	-$245K	–	1164
2022 Q4	$245K	Buy	+885	New	+$250K	0.03%	544
2021 Q3	–	Sell	-4,676	Closed	-$238K	–	525
2021 Q2	$238K	Buy	4,676 +210	+5%	+$63.6K	0.04%	380
2021 Q1	$118K	Hold	4,466	–	–	0.01%	661
2020 Q4	$118K	Buy	+4,466	New	+$1.15M	0.02%	534

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

International Assets Investment Management's BIIB Position: Q4 2024 in Review

International Assets Investment Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,852 shares — an estimated $359K sold.

International Assets Investment Management first reported a position in BIIB in Q4 2020 and held it in 10 quarters. The position peaked at $495K in Q3 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

International Assets Investment Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
International Assets Investment Management sold 1,852 Biogen shares in Q4 2024, an estimated $359K.
International Assets Investment Management first reported a position in Biogen in Q4 2020 and held it in 10 quarters.
International Assets Investment Management's Biogen position peaked at $495K in Q3 2023.
876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.